JP3081999B2 - Culture medium - Google Patents

Culture medium

Info

Publication number
JP3081999B2
JP3081999B2 JP03141229A JP14122991A JP3081999B2 JP 3081999 B2 JP3081999 B2 JP 3081999B2 JP 03141229 A JP03141229 A JP 03141229A JP 14122991 A JP14122991 A JP 14122991A JP 3081999 B2 JP3081999 B2 JP 3081999B2
Authority
JP
Japan
Prior art keywords
medium
thymus
extract
cells
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP03141229A
Other languages
Japanese (ja)
Other versions
JPH05328964A (en
Inventor
正行 藤野
尚彦 阿武
義章 赤羽
英孝 府中
裕 峯岸
教傳 安本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
MARUDAI FOOD CO Ltd
Original Assignee
Nippon Shinyaku Co Ltd
MARUDAI FOOD CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd, MARUDAI FOOD CO Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP03141229A priority Critical patent/JP3081999B2/en
Publication of JPH05328964A publication Critical patent/JPH05328964A/en
Application granted granted Critical
Publication of JP3081999B2 publication Critical patent/JP3081999B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業用の利用分野】本発明は、新規な動物細胞用培地
に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel medium for animal cells.

【0002】[0002]

【従来の技術】動物細胞を培養するためには、一般に各
種無機塩類や糖類、アミノ酸、ビタミン類などからなる
基本合成培地に栄養分補強のため動物血清を2〜20%
加えた血清含有培地が使用されてきた。
2. Description of the Related Art To culture animal cells, 2 to 20% of animal serum is generally added to a basic synthetic medium consisting of various inorganic salts, saccharides, amino acids, vitamins, etc. to supplement nutrients.
Added serum-containing media has been used.

【0003】[0003]

【発明が解決しようとする課題】ところが細胞の成長に
とって不可欠なものとして用いられている牛胎児血清
は、牛の胎児の血液を原料にすることから非常に高価で
あるので、この牛胎児血清に代る安価な物質を使用でき
るならば動物細胞用培地を安価とする上で好都合であ
る。そのため培地中の牛胎児血清の使用割合を大幅に減
少し得るような物質が求められている。
However, fetal bovine serum, which is used as an essential ingredient for cell growth, is very expensive because it uses fetal bovine blood as a raw material. If an inexpensive alternative substance can be used, it is advantageous in making the medium for animal cells inexpensive. Therefore, there is a demand for a substance capable of greatly reducing the use ratio of fetal bovine serum in the medium.

【0004】最近では、基本培地であるハムF−12培
地やイスコフ改変ダルベッコ培地(IMDM培地)など
に卵黄の低密度リポタンパク質(LDL)を添加し、さ
らに必要に応じてインシュリン、トランスフェリン、セ
レニウム、脳血清アルブミン(BAA)、リノレイン酸
などの成長因子や栄養補助物質を添加した無血清培地な
どが見られるようになった。しかし、栄養物質として
は、現在、上記したものだけでは必ずしも十分とはいい
がたく、さらに種々の動物細胞用の栄養物質の出現が望
まれている。
Recently, low-density lipoprotein (LDL) of egg yolk has been added to ham F-12 medium or Iscove's modified Dulbecco's medium (IMDM medium) which is a basic medium, and if necessary, insulin, transferrin, selenium, etc. Serum-free media to which growth factors such as brain serum albumin (BAA) and linoleic acid and nutrient supplements have been added have come to be seen. However, at present, it is not always sufficient to use the above-mentioned nutrients, and the appearance of various nutrients for animal cells is desired.

【0005】本発明者はかかる事情に鑑み、基本培地に
添加して用いることにより、牛胎児血清で代表されるよ
うな血清の使用量を大幅に低減し得るような物質につい
て鋭意研究した結果、動物細胞の培養に適した物質を見
いだし、新規な動物細胞用培地を発明するに至ったので
ある。
In view of such circumstances, the present inventors have conducted intensive studies on substances which can significantly reduce the amount of serum used, such as fetal bovine serum, when used in a basal medium. They found a substance suitable for culturing animal cells, and invented a novel medium for animal cells.

【0006】[0006]

【課題を解決するための手段】本発明は、動物の胸腺抽
出物を培地に添加することをその構成の要旨とするもの
である。
The gist of the present invention is to add an animal thymus extract to a medium.

【0007】本発明で、基本培地とは、細胞が一般的に
必要とする各種無機塩類や糖類、アミノ酸、ビタミン類
などからなる培地をいい、具体的には、イーグルMEM
培地、197培地、ダルベッコ改変イーグル培地(DM
EM培地)、イスコフ培地、イスコフ改変ダルベッコ培
地(IMDM培地)、ハムF−10培地、ハムF−12
培地、RPMI−1640培地などをあげることができ
る。また、これらの培地に少量の牛胎児血清を含有させ
たものも含める。
In the present invention, the term "basal medium" refers to a medium composed of various inorganic salts, sugars, amino acids, vitamins, and the like generally required by cells. Specifically, Eagle MEM
Medium, 197 medium, Dulbecco's modified Eagle medium (DM
EM medium), Iskov medium, Iskov modified Dulbecco medium (IMDM medium), Ham F-10 medium, Ham F-12
Media, RPMI-1640 medium and the like. In addition, those containing a small amount of fetal bovine serum in these media are also included.

【0008】本発明の動物細胞用培地は、基本培地に胸
腺抽出物を添加してなることを特徴とするものである
が、動物の胸腺抽出物とは、動物の胸腺から抽出した抽
出液やこれらを濃縮、乾燥処理したペースト、粉末のこ
とである。ここで動物とは、家畜一般を言い、好ましく
は、牛、水牛、羊、山羊、豚等を挙げることができる。
[0008] The medium for animal cells of the present invention is characterized in that a thymus extract is added to a basic medium. An animal thymus extract is an extract extracted from an animal thymus. These are pastes and powders that have been concentrated and dried. Here, the animal refers to domestic animals in general, and preferably includes cattle, buffaloes, sheep, goats, pigs, and the like.

【0009】胸腺は、脊椎動物が有する咽頭派生体のひ
とつで、免疫応答能に関与する器官である。また胸腺
は、加齢に伴って退化する器官であり、牛にあっては成
熟前で最大1kg未満と、小さいものである。
The thymus is one of the pharyngeal derivatives of vertebrates and is an organ involved in immune response. The thymus is an organ that degenerates with aging, and is small in cows, less than 1 kg before maturity.

【0010】本発明においては、胸腺抽出物の調製のた
めには、動物から採取した生胸腺のほか、これらより調
製した凍結胸腺、胸腺の脱脂品、胸腺の乾燥品等を用い
ることができる。胸腺抽出物は、動物より採取した胸腺
を清水または希食塩水中に入れて洗ったのち、水、塩溶
液、緩衝液とともにホモゲナイザーにかけ、フィルター
プレス等でろ過すれば胸腺抽出液となる。この胸腺抽出
液は、ミクロフィルターでろ過して微生物を除去して使
用することができる。
In the present invention, in order to prepare a thymus extract, not only raw thymus collected from an animal, but also frozen thymus, defatted thymus, dried thymus and the like prepared from these can be used. The thymus extract is obtained by washing the thymus collected from the animal in fresh water or diluted saline, washing with a homogenizer together with water, a salt solution and a buffer, and filtering with a filter press or the like to obtain a thymus extract. This thymus extract can be used after filtering through a microfilter to remove microorganisms.

【0011】また、胸腺抽出物は、胸腺を粉砕後、脱脂
し、または脱脂せず、あるいは乾燥粉末より水または各
種塩類溶液によって抽出したものであってもよい。抽出
物は、その上更に加熱処理して加熱凝固性の蛋白質を除
去したものであってもよい。このようにして得られた胸
腺の抽出物は、そのまま培地に用いることができるし、
更に濃縮や乾燥粉末化したのち、各種培地へ使用するこ
ともできる。基本培地に添加する胸腺抽出物の割合は、
限定するものではないが、胸腺抽出液の場合、牛胎児血
清と同様20%以下であり、濃縮物、乾燥物にあって
は、培地中へ極少量の添加であっても目的を達すことが
できる。
The thymus extract may be obtained by pulverizing the thymus and then defatting or not defatting, or extracting the thymus with water or various salt solutions from a dry powder. The extract may further be heat-treated to remove heat-coagulable proteins. The thymus extract obtained in this way can be used as it is in the medium,
Further, after concentration or dry powdering, it can be used for various media. The percentage of thymus extract added to the basal medium is
Although not limited, in the case of thymus extract, the concentration is 20% or less as in the case of fetal calf serum. it can.

【0012】本発明の動物細胞用培地を製造するには、
基本培地に、任意の割合となるように胸腺抽出液を添加
すればよい。胸腺抽出液を培地に添加すると、動物細胞
にとって栄養バランスが一層よくなるためか、動物細胞
の増殖効果が牛胎児血清添加基本培地と同等ないしはそ
れ以上となる。そのため、基本培地への牛胎児血清の使
用量を減らしても、胸腺抽出液を添加することにより、
その培地の動物細胞増殖上の効果を、牛胎児血清入り基
本培地に一段近づけることができる。
To produce the medium for animal cells of the present invention,
The thymus extract may be added to the basal medium at an arbitrary ratio. When the thymus extract is added to the medium, the nutritional balance is better for the animal cells, or the growth effect of the animal cells is equal to or higher than that of the basal medium supplemented with fetal calf serum. Therefore, even if the amount of fetal calf serum used in the basal medium is reduced, by adding the thymus extract,
The effect of the medium on the growth of animal cells can be brought closer to the basal medium containing fetal calf serum.

【0013】[0013]

【実施例】本発明を試験例及び実施例によりさらに詳細
に説明する。 試験例1 <各種胸腺検液の調製>仔牛胸腺アセトンパウダーから
の抽出液及びアセトン脱脂仔牛胸腺凍結乾燥粉末からの
抽出液:仔牛胸腺アセトンパウダー及び仔牛胸腺凍結乾
燥粉末をアセトンにて脱脂した粉末、各々1gをPBS
−(Ca、Mgフリーダルベッコ燐酸緩衝液)20mlによ
く分散させた。更に、10分間の超音波処理後、3000rpm
にて15分間遠心分離し上澄を得た、この上澄液を0.2 μ
m 孔のメンブレンフィルターでろ過して溶液とした。
The present invention will be described in more detail with reference to Test Examples and Examples. Test Example 1 <Preparation of various thymus test solutions> Extract from calf thymus acetone powder and extract from acetone-defatted calf thymus freeze-dried powder: powder obtained by defatting calf thymus acetone powder and calf thymus freeze-dried powder with acetone, 1g each in PBS
-(Ca, Mg free Dulbecco's phosphate buffer) well dispersed in 20 ml. Further, after sonication for 10 minutes, 3000rpm
The supernatant was obtained by centrifugation for 15 minutes at 0.2 μl.
The solution was filtered through a m-pore membrane filter.

【0014】F−3溶液:生仔牛胸腺より生理食塩水を
用いて抽出した上澄液を加熱処理後、遠心分離により加
熱凝固したタンパク質を除去して上澄を得た。この液に
アセトンを濃度が90%になるように加え沈澱物(F−
3)を得た。このF−3の20mgをPBS-10 mlに分散
し、10分間超音波処理した後、0.2 μm 孔のメンブレン
フィルターでろ過し、溶液を調製した。 胸腺抽出物乾燥粉末(LMT)溶液:仔牛凍結乾燥粉末
胸腺をアセトンにより脱脂後水抽出し、遠心分離して得
た上澄を液温が80℃に至るまで加熱後、遠心分離(3,000
rpm 、10分)により加熱凝固したタンパク質を除去して
上澄を得た。これを噴霧乾燥して胸腺抽出物乾燥粉末
(LMT)を得た。このLMT5gを100mlのPBS−
に分散し、オートクレーブ後 3000rpmにて15分間遠心分
離して得られた上澄を0.2 μm 孔のメンブレンフィルタ
ーにてろ過しLMT溶液を得た。
F-3 solution: The supernatant was extracted from a raw calf thymus using a physiological saline solution, and then heat-coagulated protein was removed by centrifugation to obtain a supernatant. Acetone was added to this solution to a concentration of 90%, and the precipitate (F-
3) was obtained. 20 mg of this F-3 was dispersed in 10 ml of PBS, sonicated for 10 minutes, and then filtered through a 0.2 μm pore membrane filter to prepare a solution. Thymus extract dry powder (LMT) solution: Lyophilized calf thymus was defatted with acetone, extracted with water, centrifuged, and the supernatant was heated until the liquid temperature reached 80 ° C., followed by centrifugation (3,000
(rpm, 10 minutes) to remove the protein coagulated by heating to obtain a supernatant. This was spray-dried to obtain a thymus extract dry powder (LMT). 5 g of this LMT was added to 100 ml of PBS-
The supernatant obtained by autoclaving and centrifuging at 3000 rpm for 15 minutes was filtered through a 0.2 μm pore membrane filter to obtain an LMT solution.

【0015】<培地の調製>DMEM培地にウシ胎児血
清(FBS)を1%添加した培地を基本培地とし、上記
供試検体溶液を用いて供試検体を0.01%含有する表1の
培地を調製した。 <動物細胞の培養>各培地を、96穴マイクロプレートに
75μl 宛分注し、1×105 cells/mlの18PDL(popula
tion doubling level :細胞集団分裂回数)のウシ大動
脈内皮細胞(BAE)浮遊液 75 μl を加え、プレート
端をビニールテープでシールし、37℃の炭酸ガスインキ
ュベータ(5%CO2 濃度)中で培養した。培養48、72
時間後に、0.05%の濃度になるようにニュートラルレッ
ド(NR)を20mMHEPESに溶解後、1%相当のFB
Sを添加し、0.2 μm 孔のメンブレンフィルターでろ過
したNR溶液75μl を添加し、更に1時間培養してNR
を細胞に取り込ませた。NRを含んだ培養液を静かに吸
引除去した後、PBS-300μl を緩やかに加え、これを
静かに吸引除去して細胞を洗浄した。50%エタノール・
燐酸塩液200 μl を加えて1時間静置後、546 nmの吸光
度を測定した。その試験結果を表2に示した。
<Preparation of Medium> A medium obtained by adding 1% of fetal bovine serum (FBS) to a DMEM medium is used as a basic medium, and the medium of Table 1 containing 0.01% of a test sample is prepared using the above test sample solution. did. <Culture of animal cells> Transfer each medium to a 96-well microplate.
Dispense 75 μl into 1 × 10 5 cells / ml 18 PDL (popula
75 ul of bovine aortic endothelial cell (BAE) suspension (action doubling level: the number of cell population divisions) was added, the plate was sealed with vinyl tape, and the plate was cultured in a carbon dioxide incubator (5% CO 2 concentration) at 37 ° C. . Culture 48, 72
After time, neutral red (NR) is dissolved in 20 mM HEPES to a concentration of 0.05%, and then 1% equivalent of FB
S was added, and 75 μl of an NR solution filtered through a membrane filter having a pore size of 0.2 μm was added.
Was incorporated into the cells. After gently aspirating and removing the culture solution containing NR, 300 μl of PBS was gently added, and this was gently aspirated off to wash the cells. 50% ethanol
After adding 200 μl of a phosphate solution and allowing to stand for 1 hour, the absorbance at 546 nm was measured. Table 2 shows the test results.

【0016】[0016]

【表1】 試験の結果、培養48時間目のNRの取り込みは、対照区
(DMEM培地+1%FBS)と比較し、アセトンパウ
ダー及びアセトン脱脂品、LMTの各検液添加区はNR
の取り込み量が多かった。培養72時間目でも、アセトン
パウダーもしくはアセトン脱脂粉末からの抽出液の添加
区で対照区より高値を示した。NRの取り込み量は細胞
の増殖の程度と比例することから、胸腺のアセトンパウ
ダー、アセトン脱脂胸腺粉末の抽出液、LMTを添加し
た培地でBAEを培養すると、その増殖が促進されるこ
とが認められた。
[Table 1] As a result of the test, the uptake of NR at 48 hours of culture was higher than that in the control group (DMEM medium + 1% FBS).
Was large. Even after 72 hours of culturing, the value of the extract to which the extract from acetone powder or acetone defatted powder was added was higher than that of the control. Since the amount of NR uptake is proportional to the degree of cell growth, it was found that culturing BAE in a medium supplemented with thymus acetone powder, an extract of acetone-defatted thymus powder, and LMT promoted the growth. Was.

【0017】[0017]

【表2】 実施例2 仔牛凍結乾燥粉末胸腺をアセトンにより脱脂後、水抽出
して抽出液を得た。この抽出液を液温が80℃に至るまで
加熱後、遠心分離(3,000rpm 、10分)により加熱凝固し
たタンパク質を除去して上澄を得た。これを噴霧乾燥し
て胸腺抽出物乾燥粉末(LMT)を得た。 次に、ME
M培地にFBSを0〜5%添加した基本培地にこのLM
Tを0.01、0.05%添加した表3の培地を調製した。各培
地を、96穴マイクロプレートに75μl 宛分注し、細胞集
団分裂回数18回のウシ大動脈内皮細胞(BAE)浮遊液
(1×105 cells/ml)75μl を加え、37℃の炭酸ガスイ
ンキュベータ(5%CO2 濃度)中で培養した。培養
3、24、48、72時間後に、試験例1と同様NR溶液75μ
l を添加し、更に1時間培養してNRを細胞に取り込ま
せた。NRを含んだ培養液を静かに吸引除去した後、P
BS-300μl を緩やかに加え、これを静かに吸引除去し
て細胞を洗浄した。50%エタノール・燐酸塩液 200μl
を加えて1時間静置した後、BAEのNR取り込み量を
546 nmにおける吸光度で測定した結果を表3に示した。
[Table 2] Example 2 Calf freeze-dried powdered thymus was defatted with acetone and extracted with water to obtain an extract. After the extract was heated until the temperature of the extract reached 80 ° C., centrifugation (3,000 rpm, 10 minutes) was performed to remove the heat-coagulated protein to obtain a supernatant. This was spray-dried to obtain a thymus extract dry powder (LMT). Next, ME
This LM is added to a basic medium obtained by adding 0 to 5% of FBS to the M medium.
The medium of Table 3 to which T and 0.01% were added was prepared. 75 μl of each medium was dispensed into a 96-well microplate, and 75 μl of bovine aortic endothelial cell (BAE) suspension (1 × 10 5 cells / ml) with 18 cell population divisions was added thereto. (5% CO 2 concentration). After culturing for 3, 24, 48, and 72 hours, the NR solution was 75 μm as in Test Example 1.
l was added and the cells were cultured for an additional hour to incorporate NR into the cells. After gently aspirating and removing the culture solution containing NR, P
The cells were washed by gently aspirating and removing 300 μl of BS- gently. 50% ethanol / phosphate solution 200μl
, And allowed to stand for 1 hour.
Table 3 shows the results measured by the absorbance at 546 nm.

【0018】[0018]

【表3】 血清培養0〜5%FBS存在下の培養では、LMT無添
加に比べ、0.01%LMT添加区のNRの取り込みが良好
であり、LMTがBAE細胞の増殖を助長することがわ
かった。本試験ではLMTのBAE増殖への有効性が認
められた。しかし、0.05%にLMTの添加量を増加させ
ると、NRの取り込みはほとんど認められなかった。
[Table 3] In the serum culture in the presence of 0 to 5% FBS, NR uptake in the 0.01% LMT-added group was better than that in the absence of LMT, indicating that LMT promotes the proliferation of BAE cells. In this test, the efficacy of LMT on BAE growth was confirmed. However, when the amount of LMT was increased to 0.05%, almost no NR uptake was observed.

【0019】実施例3 DMEM培地を基本培地とし表4の培地を調製した。こ
の培地を3.5 cmφのペトリディッシュに入れ、35 PDLの
ヒト胎児肺線維芽細胞(WI−38)を2×104cellsと
なるように撒き、37℃の炭酸ガスインキュベータ中で培
養した。培養24、48、72、120 、168 時間目に、トリプ
シン処理により細胞を回収した後、トリパンブルー染色
して生細胞数を計数した測定結果を表5に示した。
Example 3 A medium shown in Table 4 was prepared using a DMEM medium as a basic medium. This medium was placed in a 3.5 cmφ petri dish, 35 PDL human fetal lung fibroblasts (WI-38) were seeded at 2 × 10 4 cells, and cultured in a 37 ° C. carbon dioxide incubator. At 24, 48, 72, 120 and 168 hours after the culture, the cells were recovered by trypsin treatment, stained with trypan blue, and the number of viable cells was counted.

【表4】 [Table 4]

【表5】 対照区に比較してLMTを 0.001%添加した培地で培養
した場合、24時間目以降常に生細胞数が多かった。LM
T0.01%添加区では、培養 120時間目までは対照区と同
数で推移したが、 168時間目に至って生細胞数が少なく
なった。
[Table 5] When cultured in a medium supplemented with 0.001% LMT as compared to the control, the number of viable cells was always higher after 24 hours. LM
In the group in which T0.01% was added, the number of cells remained the same as that in the control group up to the 120th hour of culture, but the number of viable cells decreased until 168 hours.

【0020】実施例4 DMEM培地を基本培地とし表6の培地を調製した。各
培地にヒト胎児肺線維芽細胞(WI−38)を浮遊し、
この細胞浮遊液 200μl を96穴マイクロプレートに添加
し2×103cells/plateとし、24、48、72、120 、168 時
間培養の後、NRの取り込みを観察した。結果を表7に
示した。LMTを 0.001%添加した培地で培養した細胞
のNRの取り込みは、培養120及び168 時間目に有意に
高くなった。LMTを0.01%添加した培地では、培養12
0 時間目までは対照区と同等のNR取り込みをみせた
が、培養168 時間目では低くなった。
Example 4 A medium shown in Table 6 was prepared using a DMEM medium as a basic medium. Floating human fetal lung fibroblasts (WI-38) in each medium,
200 μl of this cell suspension was added to a 96-well microplate to give 2 × 10 3 cells / plate, and after 24, 48, 72, 120 and 168 hours of culturing, the uptake of NR was observed. The results are shown in Table 7. The uptake of NR in cells cultured in a medium supplemented with 0.001% LMT was significantly increased at 120 and 168 hours of culture. In a medium supplemented with 0.01% LMT, the culture
Up to the 0th hour, NR uptake was equivalent to that of the control group, but decreased at the 168th hour of culture.

【表6】 [Table 6]

【表7】 [Table 7]

───────────────────────────────────────────────────── フロントページの続き (72)発明者 赤羽 義章 京都市南区吉祥院西ノ庄門口町14番地 日本新薬株式会社内 (72)発明者 府中 英孝 大阪府高槻市緑町21番3号 丸大食品株 式会社内 (72)発明者 峯岸 裕 大阪府高槻市緑町21番3号 丸大食品株 式会社内 (72)発明者 安本 教傳 京都市左京区岩倉中在地町34番地の14 審査官 光本 美奈子 (56)参考文献 特開 昭60−137284(JP,A) 特開 昭64−90199(JP,A) (58)調査した分野(Int.Cl.7,DB名) C12N 5/00 WPI(DIALOG)──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Yoshiaki Akabane 14 Nishinoshomonguchicho, Kichijoin, Minami-ku, Kyoto Nippon Shinyaku Co., Ltd. (72) Inventor Hidetaka Fuchu 21-3 Midoricho, Takatsuki-shi, Osaka Marudai Food Co., Ltd. (72) Inventor Yutaka Minegishi 21-3 Midoricho, Takatsuki-shi, Osaka Marudai Foods Co., Ltd. (72) Inventor Kyoden Yasumoto 34 Inspector 34-34, Iwakura-nakazai-cho, Sakyo-ku, Kyoto Minako Moto (56) References JP-A-60-137284 (JP, A) JP-A-64-90199 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) C12N 5/00 WPI (DIALOG)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 基本培地に動物の胸腺抽出物を添加して
なることを特徴とする動物細胞用培地
1. A medium for animal cells characterized by adding an animal thymus extract to a basic medium.
JP03141229A 1991-05-16 1991-05-16 Culture medium Expired - Lifetime JP3081999B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03141229A JP3081999B2 (en) 1991-05-16 1991-05-16 Culture medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03141229A JP3081999B2 (en) 1991-05-16 1991-05-16 Culture medium

Publications (2)

Publication Number Publication Date
JPH05328964A JPH05328964A (en) 1993-12-14
JP3081999B2 true JP3081999B2 (en) 2000-08-28

Family

ID=15287118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03141229A Expired - Lifetime JP3081999B2 (en) 1991-05-16 1991-05-16 Culture medium

Country Status (1)

Country Link
JP (1) JP3081999B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4513C1 (en) * 2016-11-21 2018-04-30 Общественное Учреждение "Научно-Практический Институт Биотехнологий В Зоотехники И Ветеринарной Медицине" Protective medium for cryopreservation of ram seminal material

Also Published As

Publication number Publication date
JPH05328964A (en) 1993-12-14

Similar Documents

Publication Publication Date Title
US7270829B2 (en) Industrial production of meat using cell culture methods
CN103243071B (en) Clinical-grade human mesenchymal stem cell serum-free complete medium
WO2017124921A9 (en) Walnut oligopeptide powder, and preparation method and application thereof
KR102144593B1 (en) Composition of serum-free medium containing human stem cell-derived exosomes for cell culture
ES2655213T3 (en) Method for producing a low-ash poultry plasma protein powder using poultry blood
CN110463689B (en) Primary hepatocyte cryopreservation liquid, hepatocyte cryopreservation method and hepatocyte recovery method
CA1230553A (en) Process for the preparation of a biologically active extract
JPH0779684B2 (en) Bifidobacteria growth promoting composition
RU2007137828A (en) NUTRITIONAL COMPOSITIONS FOR MODULATION OF VITAMIN C BIOAVAILABILITY
US4100022A (en) Process for preparing a curing agent for myelogenic leukemia
JP3081999B2 (en) Culture medium
CN107568470A (en) A kind of liquid feed for promoting the growth of spider spiderling and preparation method thereof
KR20230077644A (en) Method for producing cultured meat using FBS(fetal bovine serum) substitute derived from slaughter by-products
CN109810936A (en) A kind of cell culture based additive
Hohl et al. NUTRITION OF CELLULAR SLIME MOLDS II. Growth of Polysphondylium pallidum in Axenic Culture
CN109400669B (en) Extraction method and application of micromolecular protein of walnut kernel peel
JP7458990B2 (en) Method for improving the solubility of polymethoxyflavonoids
WO2023127970A1 (en) Cell proliferation medium for producing cultured meat
WO2023127960A1 (en) Differentiation suppression agent for muscle tissue-derived cells
JP2667421B2 (en) Bifidobacterium activator, Bifidobacterium food and drink and medium containing the same
JPH1052291A (en) Preparation of polyamine
JPS63129994A (en) Production of human-originated physiologically active substance
JP2000290194A (en) Protective agent for infection of pathogenic bacterium and virus
Liang et al. Guidelines for separation of natural extracellular vesicles
JP2604332B2 (en) Bifidobacterium growth promotion feed

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080630

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090630

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100630

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110630

Year of fee payment: 11

EXPY Cancellation because of completion of term